Krishnan Rajesh's most recent trade in Oncternal Therapeutics Inc was a trade of 17,700 Stock Option done . Disclosure was reported to the exchange on Feb. 14, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics Inc | Krishnan Rajesh | CTO/CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 17,700 | 17,700 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Rajesh Krishnan | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.50 per share. | 03 Jan 2024 | 11,838 | 44,019 (0%) | 0% | 0.5 | 5,873 | Common Stock |
| Oncternal Therapeutics Inc | Rajesh Krishnan | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. | 03 Jul 2023 | 10,897 | 55,857 (0%) | 0% | 0.4 | 3,923 | Common Stock |
| Oncternal Therapeutics Inc | Rajesh Krishnan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2023 | 220,000 | 220,000 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Rajesh Krishnan | Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 03 Jan 2023 | 6,238 | 66,754 (0%) | 0% | 1.0 | 6,363 | Common Stock |
| Oncternal Therapeutics Inc | Rajesh Krishnan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 43,125 | 72,992 (0%) | 0% | 0 | Common Stock | |
| Oncternal Therapeutics Inc | Rajesh Krishnan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 28,750 | 28,750 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Rajesh Krishnan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 177,050 | 177,050 | - | - | Stock Option | |
| Oncternal Therapeutics Inc | Rajesh Krishnan | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 29,867 | 29,867 (0%) | 0% | 0 | Common Stock |